• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.03% Nasdaq Up1.29%

    Synta Pharmaceuticals Corp. (SNTA)

    -NasdaqGM
    2.39 Up 0.14(6.22%) May 1, 4:00PM EDT
    |After Hours : 2.39 0.00 (0.00%) May 1, 4:29PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue -   -   147  
    Cost of Revenue -   -   -  
    Gross Profit -   -   147  
    Operating Expenses
    Research Development68,205  71,860  49,412  
    Selling General and Administrative15,746  15,699  11,676  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (83,951) (87,559) (60,941)
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -  
    Earnings Before Interest And Taxes(83,951)(87,559)(60,941)
    Interest Expense2,210  2,633  1,849  
    Income Before Tax(86,161)(90,192)(62,790)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(86,161)(90,192)(62,790)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (86,161) (90,192) (62,790)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (86,161) (90,192) (62,790)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.